TIMP3 has been identified as an ovarian cancer-specific biomarker of cancer-associated fibroblasts (CAFs) associated with cancer progression, chemoresistance, and poor prognosis by integrating several bioinformatic approaches [155]. This evidence concerns the gene TIMP3 and cancer.